Valuation: DexCom, Inc.

Market Cap 31.61B 28.22B 25.9B 23.56B 44.17B 2,993B 45.05B 309B 125B 1,580B 119B 116B 4,989B P/E 2026 *
33.3x
P/E 2027 * 28.1x
Enterprise Value 31.27B 27.92B 25.62B 23.3B 43.69B 2,960B 44.56B 306B 123B 1,562B 117B 115B 4,935B EV / Sales 2026 *
5.98x
EV / Sales 2027 * 5.32x
Free-Float
89.49%
Yield 2026 *
-
Yield 2027 * -
1 day+3.00%
1 week+7.88%
Current month+3.00%
1 month-0.70%
3 months+1.57%
6 months+38.16%
Current year+27.71%
1 week 77.69
Extreme 77.69
85.24
1 month 76.52
Extreme 76.52
88.87
Current year 56.72
Extreme 56.72
92.59
1 year 54.11
Extreme 54.11
92.59
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/28/26 Sell

Head of Human Resources

-2,565 0.0007%
9/15/26 Sell

Compliance Officer

-1,700 0.0005%
9/15/26 Sell

Director

-6,539 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
+3.00%+7.88%+45.59%-9.51% 30.69B
+3.73%+5.03%-10.89%+14.80% 184B
+2.85%+4.75%+9.47%+37.73% 118B
+5.12%+0.22%-13.88%+10.27% 111B
+1.41%+6.80%-41.10%+6.45% 94.58B
+2.12%+2.38%+0.01%+75.79% 63.13B
-5.48%-5.08%-1.24%+63.86% 55.66B
+0.36%+1.13%+11.13%-22.40% 53.9B
+21.85%+17.79%+6.69%+60.13% 43.42B
+2.23%+4.28%+1.04%-7.87% 34.68B
Average +3.72%+1.91%+0.68%+22.92% 78.91B
Weighted average by Cap. +3.41%+2.44%-5.14%+22.95%

Financials

2026 *2027 *
Net sales 5.23B 4.67B 4.28B 3.9B 7.31B 495B 7.45B 51.16B 20.62B 261B 19.62B 19.2B 825B 5.77B 5.15B 4.73B 4.3B 8.06B 546B 8.22B 56.46B 22.76B 288B 21.66B 21.19B 911B
Net income 978M 873M 801M 729M 1.37B 92.58B 1.39B 9.57B 3.86B 48.87B 3.67B 3.59B 154B 1.14B 1.02B 932M 847M 1.59B 108B 1.62B 11.13B 4.49B 56.82B 4.27B 4.18B 179B
Net Debt -343M -307M -281M -256M -480M -32.52B -489M -3.36B -1.35B -17.16B -1.29B -1.26B -54.21B -888M -792M -727M -661M -1.24B -84.03B -1.26B -8.69B -3.5B -44.35B -3.33B -3.26B -140B
Projected Income Statement - Annual - DexCom, Inc.
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
26-11-02 US$84.76 +3.00% 4,062,981
26-10-30 US$82.29 +2.95% 8,637,526
26-10-29 US$79.93 +1.67% 5,923,570
26-10-28 US$78.62 +0.08% 5,371,695
26-10-27 US$78.56 -0.01% 5,159,480
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - DexCom, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
84.76USD
Average target price
98.15USD
Spread / Average Target
+15.80%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DexCom, Inc.
  1. Stock Market
  2. Stocks
  3. DXCM Stock